199 related articles for article (PubMed ID: 32413285)
21. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity.
D'Sa-Eipper C; Subramanian T; Chinnadurai G
Cancer Res; 1996 Sep; 56(17):3879-82. PubMed ID: 8752150
[TBL] [Abstract][Full Text] [Related]
22. Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor.
Kucharczak JF; Simmons MJ; Duckett CS; Gélinas C
Cell Death Differ; 2005 Sep; 12(9):1225-39. PubMed ID: 16094403
[TBL] [Abstract][Full Text] [Related]
23. µ-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis.
Valero JG; Cornut-Thibaut A; Jugé R; Debaud AL; Giménez D; Gillet G; Bonnefoy-Bérard N; Salgado J; Salles G; Aouacheria A; Kucharczak J
PLoS One; 2012; 7(6):e38620. PubMed ID: 22745672
[TBL] [Abstract][Full Text] [Related]
24. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
25. Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
Frappier V; Jenson JM; Zhou J; Grigoryan G; Keating AE
Structure; 2019 Apr; 27(4):606-617.e5. PubMed ID: 30773399
[TBL] [Abstract][Full Text] [Related]
26. Deciphering the crucial residues involved in heterodimerization of Bak peptide and anti-apoptotic proteins for apoptosis.
Marimuthu P; Singaravelu K
J Biomol Struct Dyn; 2018 May; 36(6):1637-1648. PubMed ID: 28511583
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Bfl-1 with N-aryl maleimides.
Cashman JR; MacDonald M; Ghirmai S; Okolotowicz KJ; Sergienko E; Brown B; Garcia X; Zhai D; Dahl R; Reed JC
Bioorg Med Chem Lett; 2010 Nov; 20(22):6560-4. PubMed ID: 20933419
[TBL] [Abstract][Full Text] [Related]
28. Last but not least: BFL-1 as an emerging target for anti-cancer therapies.
Wang G; Diepstraten ST; Herold MJ
Biochem Soc Trans; 2022 Aug; 50(4):1119-1128. PubMed ID: 35900226
[TBL] [Abstract][Full Text] [Related]
29. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
[TBL] [Abstract][Full Text] [Related]
30. Discovery and optimization of (2-naphthylthio)acetic acid derivative as selective Bfl-1 inhibitor.
Niu P; Xu H; Fan M
Bioorg Med Chem Lett; 2024 Mar; 101():129658. PubMed ID: 38373466
[TBL] [Abstract][Full Text] [Related]
31. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C
Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464
[TBL] [Abstract][Full Text] [Related]
32. Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL.
Dutta S; Ryan J; Chen TS; Kougentakis C; Letai A; Keating AE
J Mol Biol; 2015 Mar; 427(6 Pt B):1241-1253. PubMed ID: 25451027
[TBL] [Abstract][Full Text] [Related]
33. The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.
Tarte K; Jourdan M; Veyrune JL; Berberich I; Fiol G; Redal N; Shaughnessy J; Klein B
Br J Haematol; 2004 May; 125(3):373-82. PubMed ID: 15086420
[TBL] [Abstract][Full Text] [Related]
34. Structural biology of the Bcl-2 family of proteins.
Petros AM; Olejniczak ET; Fesik SW
Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
[TBL] [Abstract][Full Text] [Related]
35. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
36. Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.
Opferman JT
FEBS J; 2016 Jul; 283(14):2661-75. PubMed ID: 26293580
[TBL] [Abstract][Full Text] [Related]
37. C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1.
Brien G; Debaud AL; Robert X; Oliver L; Trescol-Biemont MC; Cauquil N; Geneste O; Aghajari N; Vallette FM; Haser R; Bonnefoy-Berard N
J Biol Chem; 2009 Oct; 284(44):30257-63. PubMed ID: 19759007
[TBL] [Abstract][Full Text] [Related]
38. Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists.
Rega MF; Reed JC; Pellecchia M
Bioorg Chem; 2007 Apr; 35(2):113-20. PubMed ID: 16996562
[TBL] [Abstract][Full Text] [Related]
39. Experimental Characterization of the Binding Affinities between Proapoptotic BH3 Peptides and Antiapoptotic Bcl-2 Proteins.
Kong W; Zhou M; Li Q; Fan W; Lin H; Wang R
ChemMedChem; 2018 Sep; 13(17):1763-1770. PubMed ID: 30084216
[TBL] [Abstract][Full Text] [Related]
40. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.
Chan SL; Yu VC
Clin Exp Pharmacol Physiol; 2004 Mar; 31(3):119-28. PubMed ID: 15008953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
